000			01374 a2200385 4500
005			20250515000637.0
264		0	_c20051208
008			200512s 0 0 ger d
022			_a0340-2592
024	7		_a10.1007/s00120-005-0879-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aWirth, M P
245	0	0	_a[PSA recurrence after primary curative therapy--local or systemic? When is a second curative therapy still possible?]. _h[electronic resource]
260			_bDer Urologe. Ausg. A _cSep 2005
300			_a997-1004, 1006-7 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAftercare _xmethods
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplasm Recurrence, Local _xblood
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aPractice Patterns, Physicians'
650	0	4	_aPrognosis
650	0	4	_aProstate-Specific Antigen _xblood
650	0	4	_aProstatectomy
650	0	4	_aProstatic Neoplasms _xblood
650	0	4	_aRisk Assessment _xmethods
650	0	4	_aRisk Factors
650	0	4	_aTreatment Outcome
700	1		_aEngelhardt, F M
773	0		_tDer Urologe. Ausg. A _gvol. 44 _gno. 9 _gp. 997-1004, 1006-7
856	4	0	_uhttps://doi.org/10.1007/s00120-005-0879-4 _zAvailable from publisher's website
999			_c15769267 _d15769267